Webdisclosure.com

Search

INVENTIVA (EPA:IVA) Inventiva announces FDA decision that Fast Track designation granted to lanifibranor in NASH encompasses the treatment of NASH with compensated cirrhosis

Directive transparence : information réglementée

21/09/2021 22:00